These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block. Wilson BL, Israel AK, Lott Limbach AA. J Am Soc Cytopathol; 2021; 10(2):225-230. PubMed ID: 33092993 [Abstract] [Full Text] [Related]
7. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization. Nwanze J, Cohen C, Schmitt AC, Siddiqui MT. Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661 [Abstract] [Full Text] [Related]
15. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB. Mod Pathol; 2011 Oct; 24(10):1295-305. PubMed ID: 21572401 [Abstract] [Full Text] [Related]
16. Strong SOX10 expression in human papillomavirus-related multiphenotypic sinonasal carcinoma: report of 6 new cases validated by high-risk human papillomavirus mRNA in situ hybridization test. Hsieh MS, Lee YH, Jin YT, Huang WC. Hum Pathol; 2018 Dec; 82():264-272. PubMed ID: 30071233 [Abstract] [Full Text] [Related]
19. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma. Kerr DA, Arora KS, Mahadevan KK, Hornick JL, Krane JF, Rivera MN, Ting DT, Deshpande V, Faquin WC. Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378 [Abstract] [Full Text] [Related]